Pathogenesis of tendon rupture secondary to fluoroquinolone therapy

Orthopaedic Nursing

Volumn 26, Issue 3, 2007, Pages 175-182

  Childs, Sharon G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLONE DERIVATIVE;

CHEMICALLY INDUCED DISORDER; HISTOLOGY; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; RUPTURE; TENDINITIS; TENDON;

FLUOROQUINOLONES; HUMANS; RISK FACTORS; RUPTURE, SPONTANEOUS; TENDINOPATHY; TENDONS;

EID: 34249828157     PISSN: 07446020     EISSN: 1542538X     Source Type: Journal    
DOI: 10.1097/01.NOR.0000276969.09808.2c     Document Type: Review

References (44)

1. Atkinson, T. S., & Easley, M. (2001). Complete rupture of Achilles tendon. Medscape Orthopaedics and Sports Medicine, 5(3), 1-22. Retrieved September 16, 20006, from www.medscape.com/viewarticle/408535_print
2. Bernard-Beaubois, K., Hecquet, C., Hayem, Q., Rat, P., & Adolphe, M. (1998). In vitro study of cytotoxicity of quinolones on rabbit tenocytes. Cell Biology and Toxicology, 14, 283-292.
3. Bhandari, M., Guyatt, G. H., Siddiqi, F., Morrow, F., Bussi, J., Leighton, R. K., et al. (2002). Treatment of acute Achilles tendon rupture: A systematic overview and meta-analysis. Clinics of Orthopaedics, 400, 190-200.
4. Casparian, J. M., Luchi, M., Moffet, R. E., & Hinthorn, D. (2000). Quinolone and tendon ruptures. Southern Medical Journal, 93(4), 392-396.
5. Corps, A. N., Robinson, A. H., Movin, T., Costa, M. L. Hazleman, B. L., & Riley, G. P. (2006). Increased expression of aggrecan and biglycan in Achilles tendinopathy. Rheumatology (Oxford), 45(3), 291-294.
6. Gelberman, R., Goldberg, V., An, K., & Banes, A. (1991). Tendon. In S. Woo & J. Buckwalter (Eds.), Injury and repair of the musculoskeletal soft tissues. (pp. 5-40). Parkridge, IL: American Academy of Orthopaedics.
7. Gravelee, J. R., Hatch, R. L., & Galea, A. M. (2000). Achilles tendon rupture: A challenging diagnosis. Journal of the American Board of Family Practice, 13(5), 371-373.
8. Gold, L., & Igra, H. Levofloxacin-induced rupture: A case report and review of the literature. Journal of the American Board of Family Practice, 16(5), 458-460.
9. Haddow, L. J., Sekhar, C., Hajela, V., & Rao, G. G. (2003). Spontaneous Achilles tendon rupture in patients with Levofloxacin. Journal of Antimicrobial Chemotherapy, 5(3), 747-748.
10. Harrell, R. M. (1999). Fluoroquinolone-induced tendinopathy: What do we really know? Southern Medical Journal, 92, 622-625.
11. Jones, D. M. (2001). What is the risk of tendonitis with fluoroquinolone use? Medscape Family Medicine/Primary Care, 3(2). Retrieved August 17, 2006, from www.medscape.com/viewarticle/412524_print
12. Jorgensen, C., Anaya, J. M., Didry, C., Canoves, F., Serre, I., Baldet, P., et al. (1991). Arthropathy and tendinopathy in the Achilles tendon from pefloxacin. Rheumatology Review, 58, 623-625.
13. Jozsa, L., & Kannus, P. (1997). Human tendons. Champaign, IL: Human Kinetics.
14. Khan, K. M., Cook, J. L., Bonar, F., Harcourt, P., & Astrom, M. (1999). Histopathology of common Tendinopathies. Update and implications for clinical management. Sports Medicine, 27(6), 393-408.
15. Khan, K. M., Cook, J. L., Maffulli, N., & Kannus, P. (2000). Where is the pain coming from in tendinopathy? It may be biochemical, not only structural in origin. British Journal of Sports Medicine, 34, 81-83.
16. Khan, K. M., Cook, J. L., Kannus, P., Maffulli, N., & Bonar, S. F. (2002). Time to abandon the tendinitis myth. British Medical Journal, 324, 626-627.
17. Khaliq, Y., & Zhanel, G. G. (2005). Musculoskeletal injury associated with fluoroquinolone antibiotics. Clinics in Plastic Surgery, 32(4), 495-502.
18. Ljung, B. O., Lorsgren, S., & Frieden, J. (1999). Substance P and Calcitonin gene-related peptide expression at the extensor carpi radialis brevis muscle origin: Implications for the etiology of tennis elbow. Journal of Orthopaedic Research, 17, 554-559.
19. Marsolis, D., & Frenette, J. (2005). Inflammation and tendon healing. Medicine and Science, 2(2), 181-186.
20. McGarvey, W. C., Singh, D., & Trevino, S. G. (1996). Partial Achilles tendon rupture associated with fluoroquinolone antibiotics: A case report and literature review. Foot and Ankle International, 17, 494-498.
21. Medscape. (2006). Fluoroquinolone tendon warning urged by consumer group and State of Illinois. Retrieved November 15, 2006, from www.medscape.com/ viewarticle/543875_print
22. Meissner, A., Borner, K., & Koeppe, P. (1990). Concentration of ofloxacin in human bone and cartilage. Journal of Antimicrobials and Chemotherapy, 26:69-74.
23. Movin, R. L, Gad, A., & Grenther, P. (1997). Pathology of Achilles tendon in association with Ciprofloxacin treatment. Foot and Ankle International, 18, 297-299.
24. Myerson, M. S. (1999). Achilles tendon ruptures. Instructional Course Lectures, 48, 219-230.
25. Nordin, M., Lorenz, T., & Campello, M. (2001). Biomechanics of tendons and ligaments. In M. Nordin and V. Frankel (Eds.), Basic biomechanics of the musculoskeletal system (3rd ed.) (pp. 102-125). Philadelphia: Lippincott Williams & Wilkins.
26. Peterson, W., & Laprell, H. (1998). Insidious rupture of the Achilles tendon after Ciprofloxacin-induced tendinopathy. A case report. Unfallchirurg, 101, 731-734.
27. Petersen, W., Pufe, T., Kurz, B., Mentlein, R., & Tillmann, B. (2002). Angiogenesis in fetal tendon development: Spatial and temporal expression of angiogenic peptide vascular endothelial cell growth factor. Anatomy and Embryology (Berlin), 205(4), 263-270.
28. Pufe, T., Petersen, W., Kurz, B., Tsokos, M., Tillmann, B., & Mentlein, R. (2003). Mechanical factors influence the expression of endostatin - an inhibitor of angiogenesis in tenocytes. Journal of Orthopaedic Research, 21(4), 610-616.
29. Pouzaud, F., Bernard-Beaubois, K., Thevenin, M., Warnet, J. M., Hayem, G., & Rat, P. (2003). In vitro discrimination of fluoroquinolone toxicity on tendon cells: Involvement of oxidative stress. Journal of Pharmacology and Experimental Therapeutics. Retrieved August 20, 2006, from http://jpet.aspetjournals.org/cgi/content/full/308/1/394
30. Riley, G. (2004). The pathogenesis of tendinopathy. A molecular perspective. Rheumatology, 43, 131-142.
31. Riley, G. P., Goddard, M. J., & Hazleman, B. L. (2001). Histopathological assessment and pathological significance of matrix degeneration in supraspinatus tendon. Rheumatology, 40, 229-230.
32. Rodeo, S. A., & Kazutaka, I. (1999). Pathophysiology of tendinous tissue. In E. Arendt (Ed.), Orthopaedic knowledge update: Sports medicine 2 (pp. 29-36). Rosemont, IL: American Academy of Orthopaedics.
33. Scutt, N., Rolf, C. G., & Scutt, A. (2006). Glucocorticoids inhibit tenocyte proliferation and tendon progenitor cell recruitment. Journal of Orthopaedic Research, 24(2), 173-182.
34. Sendzik, J., Shakibaei, M., Schafer-Korting, M., & Stahlmann, R. (2005). Fluoroquinolone cause changes in extracellular matrix, signaling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology, 212(1), 24-36.
35. Shakibaei, M., Pfister, K., Schwabe, R., Vormann, J., & Stahlmann, R. (2000). Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet. Antimicrobial Agents and Chemotherapy, 44(2), 261-266.
36. Simonin, M. A., Gegout-Pottie, P., Minn, A., Gillet, P., Netter, P., & Terlain, B. (2000). Pefloxacin-induced Achilles tendon toxicity in rodents: Biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrobial Agents and Chemotherapy, 44(4), 867-872.
37. Stahlmann, R., & Lode, H. (2003). Fluoroquinolone in the elderly: Safe considerations. Drugs and Aging, 20(4), 289-302.
38. Stahlmann, R., & Lode, H. (1999). Toxicity of quinolones. Drugs, 58(S-2), 37-42.
39. Theobald, P., Benjamin, M., Nokes, L., & Pugh, N. (2005). Review of the vascularization of human Achilles tendon. Injury, 36(11), 1267-1272.
40. Williams, R. J., Attia, R., Wickiewicz, T. L., & Hannafin, J. A. (2000). The effect of Ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. American Journal of Sports Medicine, 28(3), 364-369.
41. Woo, S. L-Y., An, K. N., Frank, C. C., Livesay, G. A., Ma, B. C., Zeminski, J., et al. (2000). Anatomy, biology, and biomechanics of tendon and ligament. In J. Buckwalter, T. Einhorm, & S. Simon (Eds.), Orthopaedic basic science: biology and biomechanics of the musculoskeletal system. (2nd ed.) (pp. 581-616.) Chicago, IL: American Academy of Orthopaedic Surgeons.
42. Yuan, J., Murrel, G. A., Trickett, A., Landtmeters, M., Knoops, B., & Wang, M. X. (2004). Overexpression of antioxidant enzyme Peroxiridoxin protects human tendon cells against apoptosis and of cellular function during oxidative stress. Biochim Biophys Acta, 1693(1), 37-45.
43. Zabraniecki, L., Negrier, I., & Vergne, P. (1996). Fluoroquinolone induced tendinopathy: Report of 6 cases. Journal of Rheumatology, 23, 516-520.
44. Zantop, T., Tillmann, B., & Petersen, W. (2003). Quantitative assessment of blood vessels of the human Achilles tendon: An immunohistochemical cadaver study. Archives of Orthopaedic Trauma and Surgery, 123(9), 501-504.